These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1997 related articles for article (PubMed ID: 28736335)

  • 1. TFOS DEWS II Definition and Classification Report.
    Craig JP; Nichols KK; Akpek EK; Caffery B; Dua HS; Joo CK; Liu Z; Nelson JD; Nichols JJ; Tsubota K; Stapleton F
    Ocul Surf; 2017 Jul; 15(3):276-283. PubMed ID: 28736335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TFOS DEWS II Diagnostic Methodology report.
    Wolffsohn JS; Arita R; Chalmers R; Djalilian A; Dogru M; Dumbleton K; Gupta PK; Karpecki P; Lazreg S; Pult H; Sullivan BD; Tomlinson A; Tong L; Villani E; Yoon KC; Jones L; Craig JP
    Ocul Surf; 2017 Jul; 15(3):539-574. PubMed ID: 28736342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TFOS DEWS II pathophysiology report.
    Bron AJ; de Paiva CS; Chauhan SK; Bonini S; Gabison EE; Jain S; Knop E; Markoulli M; Ogawa Y; Perez V; Uchino Y; Yokoi N; Zoukhri D; Sullivan DA
    Ocul Surf; 2017 Jul; 15(3):438-510. PubMed ID: 28736340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TFOS DEWS II Tear Film Report.
    Willcox MDP; Argüeso P; Georgiev GA; Holopainen JM; Laurie GW; Millar TJ; Papas EB; Rolland JP; Schmidt TA; Stahl U; Suarez T; Subbaraman LN; Uçakhan OÖ; Jones L
    Ocul Surf; 2017 Jul; 15(3):366-403. PubMed ID: 28736338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Definition and Diagnostic Criteria of Dry Eye Disease: Historical Overview and Future Directions.
    Shimazaki J
    Invest Ophthalmol Vis Sci; 2018 Nov; 59(14):DES7-DES12. PubMed ID: 30481800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DRY EYE DISEASE. A REVIEW.
    Zemanová M
    Cesk Slov Oftalmol; 2021; 77(3):107–119. PubMed ID: 34107689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New international consensus statement about the definition, classification, ethiology, diagnostics and therapy of dry eye (TFOS DEWS II)].
    Berta A; Tóth-Molnár E; Csutak A
    Orv Hetil; 2018 May; 159(20):775-785. PubMed ID: 29754511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Report of the Inaugural Meeting of the TFOS i(2) = initiating innovation Series: Targeting the Unmet Need for Dry Eye Treatment.
    Chao W; Belmonte C; Benitez Del Castillo JM; Bron AJ; Dua HS; Nichols KK; Novack GD; Schrader S; Willcox MD; Wolffsohn JS; Sullivan DA
    Ocul Surf; 2016 Apr; 14(2):264-316. PubMed ID: 26774910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rethinking dry eye disease: a perspective on clinical implications.
    Bron AJ; Tomlinson A; Foulks GN; Pepose JS; Baudouin C; Geerling G; Nichols KK; Lemp MA
    Ocul Surf; 2014 Apr; 12(2 Suppl):S1-31. PubMed ID: 24725379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining Dry Eye from a Clinical Perspective.
    Tsubota K; Pflugfelder SC; Liu Z; Baudouin C; Kim HM; Messmer EM; Kruse F; Liang L; Carreno-Galeano JT; Rolando M; Yokoi N; Kinoshita S; Dana R
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33291796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Novel current and future therapy options for treatment of dry eye disease].
    Messmer EM
    Ophthalmologe; 2018 Feb; 115(2):100-106. PubMed ID: 29134276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnosis of dry eye disease].
    Jacobi C; Messmer EM
    Ophthalmologe; 2018 May; 115(5):433-450. PubMed ID: 29651548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TFOS DEWS II Management and Therapy Report.
    Jones L; Downie LE; Korb D; Benitez-Del-Castillo JM; Dana R; Deng SX; Dong PN; Geerling G; Hida RY; Liu Y; Seo KY; Tauber J; Wakamatsu TH; Xu J; Wolffsohn JS; Craig JP
    Ocul Surf; 2017 Jul; 15(3):575-628. PubMed ID: 28736343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dry eye disease: identification and therapeutic strategies for primary care clinicians and clinical specialists.
    Sheppard J; Shen Lee B; Periman LM
    Ann Med; 2023 Dec; 55(1):241-252. PubMed ID: 36576348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management Strategies for Evaporative Dry Eye Disease and Future Perspective.
    Rolando M; Merayo-Lloves J
    Curr Eye Res; 2022 Jun; 47(6):813-823. PubMed ID: 35521685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007).
    Ocul Surf; 2007 Apr; 5(2):75-92. PubMed ID: 17508116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TFOS DEWS II iatrogenic report.
    Gomes JAP; Azar DT; Baudouin C; Efron N; Hirayama M; Horwath-Winter J; Kim T; Mehta JS; Messmer EM; Pepose JS; Sangwan VS; Weiner AL; Wilson SE; Wolffsohn JS
    Ocul Surf; 2017 Jul; 15(3):511-538. PubMed ID: 28736341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dry eye disease treatment: the role of tear substitutes, their future, and an updated classification.
    Barabino S; Benitez-Del-Castillo JM; Fuchsluger T; Labetoulle M; Malachkova N; Meloni M; Utheim TP; Rolando M
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8642-8652. PubMed ID: 32964952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Molecular Mechanisms Responsible for Tear Hyperosmolarity-Induced Pathological Changes in the Eyes of Dry Eye Disease Patients.
    Harrell CR; Feulner L; Djonov V; Pavlovic D; Volarevic V
    Cells; 2023 Dec; 12(23):. PubMed ID: 38067183
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 100.